✦ LIBER ✦

Preparation and immunological effectiveness of a swine influenza DNA vaccine encapsulated in chitosan nanoparticles

✍ Scribed by Kai Zhao; Xingming Shi; Yan Zhao; Haixia Wei; Qingshen Sun; Tingting Huang; Xiaoyan Zhang; Yunfeng Wang

Book ID: 116964302
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 734 KB
Volume: 29
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2011.09.029

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preparation and Efficacy of a Live Newca

Preparation and Efficacy of a Live Newcastle Disease Virus Vaccine Encapsulated in Chitosan Nanoparticles

✍ Zhao, Kai; Chen, Gang; Shi, Xing-ming; Gao, Ting-ting; Li, Wei; Zhao, Yan; Zhang 📂 Article 📅 2012 🏛 Public Library of Science 🌐 English ⚖ 969 KB

Immunological evaluation of mannosylated

Immunological evaluation of mannosylated chitosan nanoparticles based foot and mouth disease virus DNA vaccine, pVAC FMDV VP1–OmpA in guinea pigs

✍ Nanda, Raj Kishore; Hajam, Irshad Ahmed; Edao, Bedaso Mammo; Ramya, Kalaivanan; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 281 KB

Novel chitosan derivative nanoparticles

Novel chitosan derivative nanoparticles enhance the immunogenicity of a DNA vaccine encoding hepatitis B virus core antigen in mice

✍ Lei Jiang; Feng Qian; Xiaowen He; Fang Wang; Ding Ren; Ying He; Ka Li; Shuhan Su 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 752 KB

## Abstract ## Background Chitosan has been shown to possess useful properties such as non‐toxicity, high biocompatibility and non‐antigenicity that offer advantages for vaccine delivery systems. In this study, we prepared novel chitosan derivative nanoparticles as DNA vaccine carriers and the pot

Aggregation effects of gold nanoparticle

Aggregation effects of gold nanoparticles for single-base mismatch detection in influenza A (H1N1) DNA sequences using fluorescence and Raman measurements

✍ Erdene-Ochir Ganbold; Taegyeong Kang; Kangtaek Lee; So Yeong Lee; Sang-Woo Joo 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 614 KB

Safety and immunogenicity of a purified

Safety and immunogenicity of a purified hepatitis B virus vaccine prepared by using recombinant DNA technology: Zahradnik JM, Cough RB, Gerin JL, J Infect Dis 1987;155:903–908. Reprint requests: Dr. John M. Zahradnik, Influenza Research Center, Department of Microbiology and Immunology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030

📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 193 KB